Related references
Note: Only part of the references are listed.
Review
Multidisciplinary Sciences
Julie Perry et al.
Summary: This article reviews the evidence for a humoral correlate of protection (CoP) for SARS-CoV-2. The findings suggest that higher antibody levels can decrease the risk of infection but do not eliminate it completely. The CoP for different variants is yet to be determined and further research is urgently needed.
Article
Immunology
Marta C. Nunes et al.
Summary: The study found a high rate of reinfection and vaccine breakthrough infection with the Omicron variant among healthcare workers. Prior infection and high anti-spike IgG concentration were found to be protective against Omicron infection.
Article
Medicine, General & Internal
Heba N. Altarawneh et al.
Summary: An analysis of data from Qatar showed that previous infection, vaccination, and hybrid immunity all demonstrated effectiveness in protecting against symptomatic Covid-19 caused by the BA.1 and BA.2 sublineages of the Omicron variant.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Article
Multidisciplinary Sciences
Nina Breinholt Staerke et al.
Summary: Increased levels of anti-Spike IgG antibodies are associated with reduced risk of infection with the Delta variant, but not with the Omicron variant, indicating limited impact of quantitative levels of anti-Spike IgG on breakthrough infections with Omicron.
NATURE COMMUNICATIONS
(2022)
Article
Immunology
Min Hyung Kim et al.
Summary: This study aimed to evaluate the predictive role of antibody levels in the disease progression of COVID-19 in vaccinated patients with Delta and Omicron variant infections. The results showed that increased antibody levels were associated with a decrease in the occurrence of fever, hypoxia, CRP elevation, and lymphopenia.
OPEN FORUM INFECTIOUS DISEASES
(2022)
Letter
Medicine, General & Internal
Joao Malato et al.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Article
Immunology
Sheila F. Lumley et al.
Summary: In this study, it was found that anti-nucleocapsid antibodies against SARS-CoV-2 decline within a few months, with higher titers associated with longer duration. On the other hand, anti-spike IgG remained stably detected. Factors such as age, ethnicity, and symptom presentation also had an impact on antibody levels.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Medicine, General & Internal
S. F. Lumley et al.
Summary: In a longitudinal study of seropositive and seronegative health care workers undergoing asymptomatic and symptomatic SARS-CoV-2 testing, the presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Multidisciplinary Sciences
Lewis F. Buss et al.
Summary: Research indicates that the attack rate of COVID-19 in Manaus, the capital of Amazonas state in northern Brazil, reached 66% in June 2020, rising to 76% by October, higher than the estimated attack rate of 29% in Sao Paulo, southeastern Brazil, during the same period.
Review
Physiology
Varnica Bajaj et al.
Summary: The novel coronavirus has greatly impacted the world with over 72 million cases and 1.6 million deaths, mostly affecting the elderly population. Aging leads to changes in the immune system, making elderly individuals more susceptible to infections and less responsive to vaccines. Understanding age-related immune system changes is crucial for managing infectious diseases like COVID-19.
FRONTIERS IN PHYSIOLOGY
(2021)
Article
Medicine, General & Internal
Michael A. Johansson et al.
Summary: The study suggests that more than half of COVID-19 transmission may come from asymptomatic individuals, highlighting the importance of measures beyond identifying and isolating symptomatic cases in controlling the spread of the virus.
Article
Infectious Diseases
David W. Eyre et al.
Summary: This study evaluated quantitative IgG responses in a cohort of healthcare workers in Oxford, UK, finding that following mild SARS-CoV-2 infection, a certain percentage of individuals may have negative immunoassay results. This has implications for epidemiological analyses and result interpretation in individuals with a high pre-test probability.
BMC INFECTIOUS DISEASES
(2021)
Article
Medicine, General & Internal
Raymond A. Harvey et al.
Summary: Understanding the impact of serum antibodies to SARS-CoV-2 on infection susceptibility is crucial for identifying at-risk populations and vaccine deployment. Results of the study suggest that individuals with positive antibody test results initially had a higher likelihood of positive NAAT results, but this likelihood decreased significantly over time, indicating that seropositivity may be associated with protection from infection, though the duration of this protection remains uncertain and may decrease over time.
JAMA INTERNAL MEDICINE
(2021)
Editorial Material
Multidisciplinary Sciences
Shane Crotty
Article
Immunology
Krzysztof Lukaszuk et al.
Summary: The study aimed to compare anti-SARS-CoV-2 test results to evaluate the use of the WHO standard unit for measuring vaccination responses. The three assays showed varying correlations at different time points, indicating the need for further work on international standard measurements for SARS-CoV-2 Ig.
Article
Immunology
Frauke Muecksch et al.
Summary: Understanding the longitudinal trajectory of SARS-CoV-2 antibodies is crucial for diagnosis and immunity prediction. Different serological assays have varying suitability for surveillance and prediction of neutralization potency, with S-based assays better predicting neutralization levels over time.
JOURNAL OF INFECTIOUS DISEASES
(2021)
Letter
Infectious Diseases
Ensheng Dong et al.
LANCET INFECTIOUS DISEASES
(2020)
Article
Multidisciplinary Sciences
Ruiyun Li et al.
Article
Multidisciplinary Sciences
Sean L. Wu et al.
NATURE COMMUNICATIONS
(2020)
Article
Virology
Gabriel N. Maine et al.
JOURNAL OF CLINICAL VIROLOGY
(2020)
